{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:35:17Z","timestamp":1791174917378,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.msec.2013.10.038","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T02:33:49Z","timestamp":1384396429000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design"],"prefix":"10.1016","volume":"35","author":[{"given":"Umang","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krutika","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2013.10.038_bb0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0169-409X(98)00047-7","article-title":"Oral particulate delivery: status and future trends","volume":"34","author":"Hongming","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2013.10.038_bb0010","series-title":"Pharmaceutical Particulate Carriers: Therapeutic Applications","first-page":"65","article-title":"Particulate delivery: the challenge of the oral route","author":"Florence","year":"1993"},{"key":"10.1016\/j.msec.2013.10.038_bb0015","series-title":"Nanoparticulate as Drug Carriers","first-page":"613","article-title":"Polymeric nanoparticles for delivery in the gastro-intestinal tract","author":"Mayank","year":"2006"},{"key":"10.1016\/j.msec.2013.10.038_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"Anne des","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2013.10.038_bb0025","series-title":"Nanoparticle Technology for Drug Delivery","first-page":"231","article-title":"Polymeric nanoparticles for oral drug delivery","author":"Vivekananda","year":"2006"},{"key":"10.1016\/j.msec.2013.10.038_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/0929867043455909","article-title":"Nanoparticles of biodegradable polymers for clinical administration of paclitaxel","volume":"11","author":"Feng","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.msec.2013.10.038_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.biomaterials.2010.09.037","article-title":"The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of temoxifen","volume":"32","author":"Jain","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2013.10.038_bb0040","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jconrel.2008.09.042","article-title":"PLGA nanocarriers for systemic and lymphatic oral delivery of proteins and peptides","volume":"132","author":"Patronidou","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2013.10.038_bb0045","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s11095-009-9965-4","article-title":"PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat","volume":"26","author":"Bhardwaj","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.msec.2013.10.038_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00003495-199244020-00008","article-title":"Felodipine: a review of the pharmacology and therapeutic uses of the extended release formulation in cardiovascular disorders","volume":"44","author":"Todd","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.msec.2013.10.038_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-3659(98)00116-3","article-title":"PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug","volume":"57","author":"Govender","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2013.10.038_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/js950474+","article-title":"Comparative in vitro evaluation of several colloidal systems: nanoparticles, nanocapsules, and nanoemulsions as ocular drug carriers","volume":"85","author":"Calvo","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.msec.2013.10.038_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/156720110790396517","article-title":"Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation","volume":"7","author":"Yadav","year":"2010","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.msec.2013.10.038_bb0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1023\/A:1018888927852","article-title":"Body distribution of camptothecin solid lipid nanoparticles after oral administration","volume":"16","author":"Yang","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.msec.2013.10.038_bb0075","series-title":"United States Pharmacopoeia 30 National Formulary 25","first-page":"2113","year":"2007"},{"key":"10.1016\/j.msec.2013.10.038_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4899-1863-5_2","article-title":"Models for assessing drug absorption and metabolism, methods for evaluating intestinal permeability and metabolism in vitro","volume":"8","author":"Ronald","year":"1996","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.msec.2013.10.038_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2007.06.024","article-title":"Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution","volume":"123","author":"Yin","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2013.10.038_bb0090","series-title":"Pharmacological Assays","first-page":"175","article-title":"Drug discovery and evaluations","author":"Vogel","year":"2002"},{"key":"10.1016\/j.msec.2013.10.038_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(01)01120-7","article-title":"Effects of a-lipoic acid on deoxycorticosterone acetate\u2013salt-induced hypertension in rats","volume":"424","author":"Masanori","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.msec.2013.10.038_bb0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1056-8719(00)00126-X","article-title":"Direct and indirect methods used to study arterial blood pressure","volume":"44","author":"Van Vliet","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.msec.2013.10.038_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1254\/jjp.60.73","article-title":"Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs","volume":"60","author":"Kodama","year":"1992","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.msec.2013.10.038_bb0110","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1248\/yakushi.126.1377","article-title":"Effects of benidipine in a rat model of experimental angina","volume":"126","author":"Ikeda","year":"2006","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.msec.2013.10.038_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11095-008-9763-4","article-title":"Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies","volume":"26","author":"Kalaria","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.msec.2013.10.038_bb0120","series-title":"Pharmaceutical Statistics: Practical and Clinical Application","first-page":"563","author":"Bolton","year":"1997"},{"key":"10.1016\/j.msec.2013.10.038_bb0125","first-page":"1","article-title":"Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes","volume":"5","author":"Subramanian","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.msec.2013.10.038_bb0130","first-page":"281","article-title":"Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp.","volume":"5","author":"Adinarayana","year":"2002","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.msec.2013.10.038_bb0135","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine loaded PLGA nanoparticles for nose to brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.msec.2013.10.038_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(00)00364-3","article-title":"Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers","volume":"71","author":"Feng","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2013.10.038_bb0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11095-005-8418-y","article-title":"Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy","volume":"23","author":"Hariharan","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.msec.2013.10.038_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/10611860903046628","article-title":"Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic\u00aeP85, an in vitro cell line and in vivo biodistribution studies on rat model","volume":"17","author":"Shah","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.msec.2013.10.038_bb0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2006.11.061","article-title":"Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content","volume":"336","author":"Budhian","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2013.10.038_bb0160","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/02652049109021873","article-title":"Studies on the transport pathway of PBCA nanoparticles in ocular tissues","volume":"8","author":"Zimmer","year":"1991","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.msec.2013.10.038_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0169-409X(00)00120-4","article-title":"Mucoadhesive nanoparticulate systems for peptide drug delivery","volume":"47","author":"Takeuchi","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.msec.2013.10.038_bb0170","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.biomaterials.2004.07.050","article-title":"Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs","volume":"26","author":"Win","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.msec.2013.10.038_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10611860410001693706","article-title":"Issues in oral nanoparticle drug carrier uptake and targeting","volume":"12","author":"Florence","year":"2004","journal-title":"J. Drug Target."},{"key":"10.1016\/j.msec.2013.10.038_bb0180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tca.2005.09.011","article-title":"Physicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniques","volume":"439","author":"Bikiaris","year":"2005","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.msec.2013.10.038_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(02)00325-3","article-title":"Evaluation of controlled release polar lipid microparticles","volume":"244","author":"Savolainen","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2013.10.038_bb0190","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.msec.2013.10.038_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","article-title":"A simple equation for description of solute release, Fickian and anomalous release from swellable devices","volume":"5","author":"Peppas","year":"1987","journal-title":"J. Control. Release"}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493113006097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493113006097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T15:38:56Z","timestamp":1572968336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493113006097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":39,"alternative-id":["S0928493113006097"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2013.10.038","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2013.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}